Richard Heyman, Ph.D.

Richard Heyman, Ph.D.

Chair of the BoardatEnliven Therapeutics· In proxies 2023–2025

Richard Heyman, Ph.D. sits on 3 public boards.

Experience

  1. Enliven TherapeuticsPublic company · 3 yr
    • Chair of the Board2023 – Present · 3 yrStock in role +178%
  2. PMV Pharmaceuticals, Inc.Public company · 6 yr
    • Director2020 – Present · 6 yrNo stock prices for these years
  3. Yumanity Therapeutics, Inc.Public company · 6 yr
    • Director2016 – 2022 · 6 yrNo stock prices for these years
  4. BCTG Acquisition Corp.Public company · 1 yr
    • Director2020 – 2021 · 1 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?